- Cash until Q1 2019 to run operations
- Restructure (30% decrease in cost savings), no cuts in sales staff mostly admin/management
- ~20% market share in Australia & moving to a distribution network
- Optimistic on sales uptake in the U.S moving forward with a new sales structure & tactics
- Surgeons are not as far along the adoption curve as anticipated
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.001(50.0%) |
Mkt cap ! $10.02M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $10.01K | 5.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 18756669 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 47580730 | 38 |
View Market Depth
| Last trade - 10.01am 24/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |